Lorcaserin prevents or causes remission of T2DM in overweight/obese patients with or at high risk of CVD (CAMELLIA-TIMI 61)

Lorcaserin prevents or causes remission of T2DM in overweight/obese patients with or at high risk of CVD (CAMELLIA-TIMI 61) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central